VZV is a member of the human herpes virus family which causes two distinct clinical manifestations: childhood chickenpox (Varicella) and shingles (Zoster). Varicella is the outcome of the primary infection with VZV. Whereas, Zoster is the result of VZV reactivation from latently infected sensory ganglia which occurs predominantly in aging and immuno-suppressed individuals.
Applications:Suitable for use as an antigen in immunological protocols. Other applications have not been tested.
Recommended Dilutions:Optimal dilutions to be determined by researcher.
Storage and Stability:Aliquot to avoid repeated freezing and thawing and freeze at -70°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquots are stable for at least 6 months.
